The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Carcinoma, Small Cell

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinoma, Small Cell


High impact information on Carcinoma, Small Cell


Chemical compound and disease context of Carcinoma, Small Cell


Biological context of Carcinoma, Small Cell


Anatomical context of Carcinoma, Small Cell


Gene context of Carcinoma, Small Cell


Analytical, diagnostic and therapeutic context of Carcinoma, Small Cell


  1. IgG from patients with Lambert-Eaton syndrome blocks voltage-dependent calcium channels. Kim, Y.I., Neher, E. Science (1988) [Pubmed]
  2. Gallium scans for staging small cell lung cancer. Brereton, H.D., Line, B.R., Londer, H.N., O'Donnell, J.F., Kent, C.H., Johnson, R.E. JAMA (1978) [Pubmed]
  3. Antibodies against autologous tumor cell proteins in patients with small-cell lung cancer: association with improved survival. Winter, S.F., Sekido, Y., Minna, J.D., McIntire, D., Johnson, B.E., Gazdar, A.F., Carbone, D.P. J. Natl. Cancer Inst. (1993) [Pubmed]
  4. Glycolipids in human lung carcinoma of histologically different types. Yoda, Y., Gasa, S., Makita, A., Fujioka, Y., Kikuchi, Y., Hashimoto, M. J. Natl. Cancer Inst. (1979) [Pubmed]
  5. Partial purification and characterization of a peptide with growth hormone-releasing activity from extrapituitary tumors in patients with acromegaly. Frohman, L.A., Szabo, M., Berelowitz, M., Stachura, M.E. J. Clin. Invest. (1980) [Pubmed]
  6. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. Turrisi, A.T., Kim, K., Blum, R., Sause, W.T., Livingston, R.B., Komaki, R., Wagner, H., Aisner, S., Johnson, D.H. N. Engl. J. Med. (1999) [Pubmed]
  7. Serum lactate dehydrogenase in small-cell lung cancer. Van den Brande, P., Demedts, M. N. Engl. J. Med. (1989) [Pubmed]
  8. Variable content of histaminase, L-dopa decarboxylase and calcitonin in small-cell carcinoma of the lung. Biologic and clinical implications. Baylin, S.B., Weisburger, W.R., Eggleston, J.C., Mendelsohn, G., Beaven, M.A., Abeloff, M.D., Ettinger, D.S. N. Engl. J. Med. (1978) [Pubmed]
  9. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Watkins, D.N., Berman, D.M., Burkholder, S.G., Wang, B., Beachy, P.A., Baylin, S.B. Nature (2003) [Pubmed]
  10. Paraneoplastic myasthenic syndrome IgG inhibits 45Ca2+ flux in a human small cell carcinoma line. Roberts, A., Perera, S., Lang, B., Vincent, A., Newsom-Davis, J. Nature (1985) [Pubmed]
  11. Physalaemin: an amphibian tachykinin in human lung small-cell carcinoma. Lazarus, L.H., DiAugustine, R.P., Jahnke, G.D., Hernandez, O. Science (1983) [Pubmed]
  12. Effect of warfarin on survival in small cell carcinoma of the lung. Veterans Administration Study No. 75. Zacharski, L.R., Henderson, W.G., Rickles, F.R., Forman, W.B., Cornell, C.J., Forcier, R.J., Edwards, R., Headley, E., Kim, S.H., O'Donnell, J.R., O'Dell, R., Tornyos, K., Kwaan, H.C. JAMA (1981) [Pubmed]
  13. Elevation of true creatine kinase-MB in a patient with small-cell lung cancer. McGing, P.G., Kyne, F., Johnston, P., Carney, D.N. JAMA (1988) [Pubmed]
  14. Gallium 67 scans in small cell carcinoma. Bitran, J.D., Bekerman, C., Pinsky, S., DeMesteer, T., Golomb, H.M. JAMA (1979) [Pubmed]
  15. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. Fukuoka, M., Furuse, K., Saijo, N., Nishiwaki, Y., Ikegami, H., Tamura, T., Shimoyama, M., Suemasu, K. J. Natl. Cancer Inst. (1991) [Pubmed]
  16. Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Wong, A.J., Ruppert, J.M., Eggleston, J., Hamilton, S.R., Baylin, S.B., Vogelstein, B. Science (1986) [Pubmed]
  17. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer. Doyle, A., Martin, W.J., Funa, K., Gazdar, A., Carney, D., Martin, S.E., Linnoila, I., Cuttitta, F., Mulshine, J., Bunn, P. J. Exp. Med. (1985) [Pubmed]
  18. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. Kalemkerian, G.P., Slusher, R., Ramalingam, S., Gadgeel, S., Mabry, M. J. Natl. Cancer Inst. (1995) [Pubmed]
  19. Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc proto-oncogene. Johnson, B.E., Battey, J., Linnoila, I., Becker, K.L., Makuch, R.W., Snider, R.H., Carney, D.N., Minna, J.D. J. Clin. Invest. (1986) [Pubmed]
  20. Expression of insulinlike growth factor (IGF) and IGF-binding protein genes in human lung tumor cell lines. Reeve, J.G., Brinkman, A., Hughes, S., Mitchell, J., Schwander, J., Bleehen, N.M. J. Natl. Cancer Inst. (1992) [Pubmed]
  21. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors. Ball, D.W., Azzoli, C.G., Baylin, S.B., Chi, D., Dou, S., Donis-Keller, H., Cumaraswamy, A., Borges, M., Nelkin, B.D. Proc. Natl. Acad. Sci. U.S.A. (1993) [Pubmed]
  22. Human granulocyte colony-stimulating factor: biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines. Avalos, B.R., Gasson, J.C., Hedvat, C., Quan, S.G., Baldwin, G.C., Weisbart, R.H., Williams, R.E., Golde, D.W., DiPersio, J.F. Blood (1990) [Pubmed]
  23. Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer. Woll, P.J., Hodgetts, J., Lomax, L., Bildet, F., Cour-Chabernaud, V., Thatcher, N. J. Clin. Oncol. (1995) [Pubmed]
  24. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Krystal, G.W., Hines, S.J., Organ, C.P. Cancer Res. (1996) [Pubmed]
  25. Penetration of VP 16-213 into cerebrospinal fluid after high-dose intravenous administration. Postmus, P.E., Holthuis, J.J., Haaxma-Reiche, H., Mulder, N.H., Vencken, L.M., van Oort, W.J., Sleijfer, D.T., Sluiter, H.J. J. Clin. Oncol. (1984) [Pubmed]
  26. Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Sreedharan, S.P., Huang, J.X., Cheung, M.C., Goetzl, E.J. Proc. Natl. Acad. Sci. U.S.A. (1995) [Pubmed]
  27. Inhibition of protein synthesis in small cell lung cancer cells induced by the diphtheria toxin-related fusion protein DAB389 GRP. vanderSpek, J.C., Sutherland, J.A., Zeng, H., Battey, J.F., Jensen, R.T., Murphy, J.R. Cancer Res. (1997) [Pubmed]
  28. Characterization of the M(r) 190,000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cell. Almquist, K.C., Loe, D.W., Hipfner, D.R., Mackie, J.E., Cole, S.P., Deeley, R.G. Cancer Res. (1995) [Pubmed]
  29. Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16 (etoposide)-selected H69 small cell lung cancer cells. Brock, I., Hipfner, D.R., Nielsen, B.S., Jensen, P.B., Deeley, R.G., Cole, S.P., Sehested, M. Cancer Res. (1995) [Pubmed]
  30. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth. Sethi, T., Herget, T., Wu, S.V., Walsh, J.H., Rozengurt, E. Cancer Res. (1993) [Pubmed]
  31. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Sethi, T., Rintoul, R.C., Moore, S.M., MacKinnon, A.C., Salter, D., Choo, C., Chilvers, E.R., Dransfield, I., Donnelly, S.C., Strieter, R., Haslett, C. Nat. Med. (1999) [Pubmed]
  32. Phase I trial of granulocyte-macrophage colony-stimulating factor with high-dose cisplatin and etoposide for treatment of small-cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group. Shepherd, F.A., Goss, P.E., Rusthoven, J., Eisenhauer, E.A. J. Natl. Cancer Inst. (1992) [Pubmed]
  33. Worsening psoriasis after treatment with G-CSF in a patient with small-cell lung cancer. Feliu, J., Díaz, R., Contreras, F., Casado, M., Espinosa, E., Barón, M.G. J. Natl. Cancer Inst. (1997) [Pubmed]
  34. Promoter methylation and silencing of the retinoic acid receptor-beta gene in lung carcinomas. Virmani, A.K., Rathi, A., Zöchbauer-Müller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K.M., Thunnissen, F., Minna, J.D., Gazdar, A.F. J. Natl. Cancer Inst. (2000) [Pubmed]
  35. Use of SM-1 monoclonal antibody and human complement in selective killing of small cell carcinoma of the lung. Mabry, M., Speak, J.A., Griffin, J.D., Stahel, R.A., Bernal, S.D. J. Clin. Invest. (1985) [Pubmed]
WikiGenes - Universities